David Carney, MD
Urology · Johnstown, PANPI 1487663134
Payments from drug & device makers
Across 23 payments — averaging $21.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$146
- AbbVie$76
- Bioventus LLC$56
- Tolmar, Inc.$36
- Sumitomo Pharma America, Inc.$35
- Boston Scientific$29
- plus $116 from 6 others
What the payments were for
- Food & beverage$39480%
- Education$10020%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 3 | $146 |
| AbbVie(2 entities) | 5 | $76 |
| Bioventus LLC | 2 | $56 |
| Tolmar, Inc. | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Boston Scientific | 2 | $29 |
| Laborie Medical Technologies Corp. | 2 | $27 |
| Johnson & Johnson | 1 | $26 |
| Smith+Nephew | 1 | $17 |
| Axonics, Inc. | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Stryker | 1 | $14 |
How this compares
$494 in reported general payments places this provider in the 25th percentile of 596 urology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tolterodine Tartrate ErTolterodine Tartrate | 30 | $1,888 |
| Tamsulosin Hcl | 114 | $1,755 |
| Oxybutynin Chloride | 74 | $642 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 36 | $545 |
| NitrofurantoinNitrofurantoin Macrocrystal | 31 | $459 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 11 | $446 |
| Oxybutynin Chloride ErOxybutynin Chloride | 26 | $442 |
| Solifenacin Succinate | 12 | $429 |
| Finasteride | 35 | $383 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 115 | $178 |
| Ciprofloxacin Hcl | 25 | $103 |
Paid to pharmacies, not to this prescriber.
Other urology in Johnstown
- Laurence BelkoffBala Cynwyd$18.7M
- Paul SieberLancaster$12.6M
- Costas LallasPhiladelphia$3.6M
- John AndersonBethlehem$2.1M
- Jodi MaranchiePittsburgh$1.2M
- Kenneth LessansLancaster$943K
- Stanley MalkowiczPhiladelphia$882K
- Demetrius BagleyPhiladelphia$739K
- Gregory TasianPhiladelphia$645K
- Eugene PietzakPhiladelphia$544K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.